Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat Dosing Regimens in Dialysis CKD
NCT04059913Phase 4Completed
- Sponsor
- FibroGen
- Start
- Jun 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of roxadustat in anemia of chronic kidney disease (CKD-A), sponsored by FibroGen. Started Jun 2019; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT04059913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04059913.